Exploring P2X7 receptor antagonism as a therapeutic target for neuroprotection in an hiPSC motor neuron model
Alexandra E Johns, Arens Taga, Andriana Charalampopoulou, Sarah K Gross, Khalil Rust, Brett A McCray, Jeremy M Sullivan, Nicholas J Maragakis · 2024
Read Exploring P2X7 receptor antagonism as a therapeutic target for neuroprotection in an hiPSC motor neuron model by Alexandra E Johns, Arens Taga, Andriana Charalampopoulou, Sarah K Gross, Khalil Rust, Brett A McCray, Jeremy M Sullivan, Nicholas J Maragakis (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11631223.txt.
Description
Alexandra Johns and seven co-authors explored whether blocking a certain cell receptor can protect motor neurons, using human stem-cell-grown neurons, in this 2024 study. The receptor, P2X7, responds to ATP, a molecule that floods out of injured tissue. Its role on motor neurons themselves, rather than on immune cells, had not been a focus.
The team showed the receptor sits on human motor neurons and works there. Bathing the neurons in ATP killed them through this receptor, in step with the dose. A specific blocker shielded the neurons from that death. The authors argue the receptor is a fresh drug target for diseases where motor neurons die, separate from its known part in inflammation.
Catalog record
| CREATOR | Alexandra E Johns, Arens Taga, Andriana Charalampopoulou, Sarah K Gross, Khalil Rust, Brett A McCray, Jeremy M Sullivan, Nicholas J Maragakis |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |